Choose Language
Select a language for news translation.
Pfizer director and Gbank CEO bought nearly $1.7 million in shares, signaling executive confidence in their firms' growth. These insider purchases may boost in…
The FDA has approved the first mRNA vaccine for seasonal flu, allowing for faster adaptation to emerging strains and potentially improving effectiveness compar…
A new kind of flu vaccine made with mRNA technology will soon be available. Marco Bello/Bloomberg/Getty Images hide caption For the latest stories on the scie…
Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.
In a first, U.S. approves powerful new mRNA vaccine for flu The flu shot, mFlusiva, was shown in a clinical trial to be up to 27 percent more effective than a…
A younger and higher-educated base were pivotal to Abdul El Sayed’s Senate Primary win, an analysis shows.
The Food and Drug Administration (FDA) late Wednesday approved the nation’s first mRNA flu vaccine, manufactured by drugmaker Moderna. The agency approved the …
In the Democratic Republic of the Congo, the Ebola outbreak is spreading, with the number of infections rising rapidly. Declared in mid-May, this seventeenth E…
The mFlusiva vaccine will soon be available for adults aged 50 and over. After initially refusing to even review it, the US Food and Drug Administration (FDA)…
The Food and Drug Administration on Wednesday approved the U.S.’s first flu shot that uses mRNA technology: mFlusiva, from drugmaker Moderna.
UK scientists have developed a new dry powder vaccine that does not require refrigeration, potentially reducing the 50% vaccine waste caused by cold chain fail…
